Spondyloarthritis & psoriatic arthritis

Role of inflammatory burden and treatment on joint space width in psoriatic arthritis—a high-resolution peripheral quantitative computed tomography study

Arthritis Res TherPublished Cross-sectional study

Authors' conclusion

Higher inflammatory burden as reflected by longer disease duration, higher ESR levels, and damage joint count was negatively associated with mean, maximum, and minimum JSW, while suppression of inflammation using bDMARDs seems to limit the decline in JSW.

Study context

Population
Psoriatic arthritis (PsA) patients who underwent high-resolution peripheral quantitative computed tomography (HR-pQCT) of the second to fourth metacarpophalangeal joints (median age 57.0 years; median disease duration 21 years)37 (55.2%) males
Participants
67 patients
Outcome
Association between disease-related variables and JSW (JSV, mean, minimum and maximum JSW, JSW asymmetry and distribution) on HR-pQCT
Methodological detailsHR-pQCT of MCPJ 2-4, multivariable linear regression
  • HR-pQCT of MCPJ 2-4
  • Multivariable linear regression

Main finding

As reported in the abstract

Associations with joint space metrics (multivariable linear regression)
  • Males had larger joint space volume (JSV) (MCPJ 2-4), mean (MCPJ 4) and maximum joint space width (JSW) (MCPJ 3)
  • Longer disease duration (MCPJ 2-3) and higher ESR (MCPJ 3) negatively associated with mean and maximum JSW
  • Higher damage joint count negatively associated with mean and minimum JSW (MCPJ 2)
  • csDMARD use negatively associated with minimum JSW (MCPJ 3)
  • bDMARD use positively associated with minimum JSW (MCPJ 2)

Observational data: associations, not effects.

Original publication

Role of inflammatory burden and treatment on joint space width in psoriatic arthritis—a high-resolution peripheral quantitative computed tomography study. Arthritis Res Ther. Published 3 August 2023. doi:10.1186/s13075-023-03124-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.